Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Atigotatug (BMS-986012) is a humanized antibody targeting fucosylated GM1 ganglioside, used in lung cancer research.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $195 | In Stock | |
| 5 mg | $483 | In Stock | |
| 10 mg | $692 | In Stock | |
| 25 mg | $1,080 | In Stock | |
| 50 mg | $1,490 | In Stock | 
| Description | Atigotatug (BMS-986012) is a humanized antibody targeting fucosylated GM1 ganglioside, used in lung cancer research.  | 
| In vitro | Atigotatug binds to SCLC cell line specific and dose-dependent with EC50 ranges of 6 to 132 nmol/L, respectively. Atigotatug specifically binds FucGM1 with high affinity and acts as an IgG1 mAb, avoiding the need for T cell-dependent class switching. [1]  | 
| In vivo | Atigotatug (0.01 to 3 mg/kg) showed antitumor activity in human SCLC tumor xenotransplantation and PDX models. [1]  | 
| Synonyms | BMS-986012, BMS986012 | 
| Molecular Weight | 145.5kDa | 
| Smiles | #N/A | 
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.